Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Carga Global de Doenças: Estimativa e tendência temporal da carga da hanseníase no estado de Alagoas, Brasil entre 2001 a 2019

Cabral JSD, Matos DF, Bezerra L, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (2) : e44511225528.
Download PDF
Publication

Cuidado farmacêutico ambulatorial na Hanseníase / Ambulatory pharmaceutical care in Leprosy

Ramos MF, Galete J, Polisel CG. South Florida Publishing LLC. Brazilian Journal of Development. 2022; 8 (1) : 7213-7228.
Download PDF
Publication

Spatio-temporal analysis of leprosy risks in a municipality in the state of Mato Grosso-Brazilian Amazon: results from the leprosy post-exposure prophylaxis program in Brazil.

Machado LMG, dos Santos ES, Cavaliero A, et al. Infectious diseases of poverty. 2022; 11 (1) : 21.
Download PDF
Publication

Chronic type 2 reaction possibly triggered by an asymptomatic Bartonella henselae infection in a leprosy patient.

Santos L, Drummond M, França A, et al. Revista do Instituto de Medicina Tropical de Sao Paulo. 2022;
Download PDF
Publication

Development and validation of a multiplex real-time qPCR assay using GMP-grade reagents for leprosy diagnosis.

Manta F, Jacomasso T, Rampazzo R, et al. PLoS neglected tropical diseases. 2022; 16 (2) : e0009850.
Download PDF
Publication

Reimagining leprosy elimination with AI analysis of a combination of skin lesion images with demographic and clinical data

Barbieri RR, Xu Y, Setian L, et al. Elsevier BV. The Lancet Regional Health - Americas. 2022;
Download PDF
Publication

Clinical and radiological assessment of rhinomaxillary syndrome in Hansen's disease.

do Espírito Santo RB, Serafim R, Loureiro R, et al. Indian journal of dermatology, venereology and leprology. 2021;
Download PDF
Publication

Knowledge and attitude about disabilities in leprosy: Effects of an intervention grounded on the Meaningful Learning Theory.

Santana EMFD, Gonçalves de Brito KK, Nóbrega MDM, et al. Revista da Escola de Enfermagem da U S P. 2022;
Download PDF
Publication

Evaluation of Polymorphisms in Toll-Like Receptor Genes as Biomarkers of the Response to Treatment of Erythema Nodosum Leprosum.

Maciel-Fiuza M, Costa P, Kowalski TW, et al. Frontiers in medicine. 2021;
Download PDF
Publication

Evolução temporal e distribuição espacial da hanseníase em município de baixa endemicidade em São Paulo

Ramos ACV, Júnior J, Berra T, et al. FapUNIFESP (SciELO). 2022;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 75
  • Next page ››
Subscribe to Brazil

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD